Treatment with lysophosphatidic acid improves glomerulonephritis through the suppression of macrophage activation in a murine model of systemic lupus erythematosus

CONCLUSIONS: These results suggest that LPA may improve glomerulonephritis by suppressing macrophage activation in MRL/lpr mice.PMID:38436267 | DOI:10.55563/clinexprheumatol/ov6027

Source: Clinical and Experimental Rheumatology - March 4, 2024 Category: Rheumatology Authors: Wataru Nagata Eiji Takayama Keiichi Nakagawa Akiho Koizumi Yukiko Ohsawa Hiroyasu Goto Aoi Yamashiro Yuki Ishinoda Keiko Tanoue Hiroo Kumagai Naoki Oshima Toshiaki Ishizuka Source Type: research